Article by American Pain Society via Science Daily
Clinical practice recommendations include:
• Know the federal and state laws governing use of medical cannabis
• Be clear with patients about goals for therapeutic cannabis
• Counsel patients about routes of administration and potential benefits and risks, based on scientific evidence and individual symptoms, conditions and comorbidities
• Advise patients on cannabis strains, cannabinoid medications or extracts, explaining limitations due to lack of herbal/substance uniformity and regulatory oversight
• Monitor patients the same as for treatment with opioids or other controlled substances.
• Patient follow up should assess progress toward achieving treatment goals, incidence of side effects, and evidence of psycho-behavioral changes.
The authors strongly advocate that a robust research agenda is needed to fully realize the clinical potential of cannabinoid therapies. They recommend:
• Increase federal funding for pain-related cannabis research
• Broaden pain conditions being studied to include cannabis for non-neuropathic pain
• Ease regulatory restrictions that impede approvals of cannabis and cannabinoid research
• Improve access to high-quality plant cannabis for research studies
• Encourage states to collect individual and population level data on patients receiving medical cannabis.